Earth Life Sciences (OTC Pink: CLTS, $CLTS) volume has surged by more than 980% compared to its first week in August. Following the adage that “volume precedes price,” it may therefore make sense that CLTS shares also jumped by nearly 39% after that spike. Still, while impressive, the momentum is intact, with volume on Thursday eclipsing the two million mark, the highest level seen since June. Thus, it’s a fair assumption that something could be brewing at CLTS.
That’s not to infer that news has leaked, but experienced traders know that company news, good or bad, often makes its way to the gossip mill. In this case, the excellent takeaway for CLTS is that the buyers, not sellers, are stepping up to the plate. Of course, the question remains as to why investors are showing interest in this roughly $0.01 stock.
The answer may be a simple one. CLTS appears to be doing the right things at the right time to capitalize on a potentially massive revenue-generating opportunity passed over by the mainstream health platform services providers. And the better news is that its recent acquisition of the VivaHealth Service platform could deliver those revenues sooner than later.
Acquisition Of The VIVA Health Platform
In fact, that acquisition could help fuel potentially exponential growth for CLTS, noting its VivaHealth platform may be one of the few specifically designed to meet the needs of people and patients in underserved niche markets. Moreover, its differences are also advantages- and they are significant. So much so that it’s put CLTS stock in play. And after evaluating the opportunity, it could be so accretive that investors on the sidelines may want to consider jumping into the game.
Why? Because the acquisition of the VivaHealth platform immediately positions CLTS to tap into tremendous market demand by being a one-stop Internet smart-life service trading platform targeting revenue-generating opportunities from Asian elderly communities in North America (mainly serving Chinese and other Asian communities). But keep in mind, when they say “elderly,” CLTS also refers to the aging baby-boomer population, which by all measures has plenty of discretionary money to spend. So, how significant is the near-term opportunity for CLTS?
Baby Boomers Need What CLTS Has
In a word…immense. The spending power of Baby Boomers, the wealthiest generation today, spends more than $548 billion in the US markets alone each year. They also hold a reported 70% of available disposable income, allowing them to spend more than any other generation across all categories.
Better yet, at least for the companies like CLTS that target business from that group, wealth in that demographic is increasing as markets set new record highs. Aside from normal market gyrations, it’s a trend expected to continue as global growth drives company valuations higher. But the Boomers have more than money; they have needs. A huge one relates to health and self-care. And digital technology is more than a means to transform that specific service landscape; it’s the new standard.
That’s potentially excellent news for CLTS and its investors. And more than having the right assets, CLTS is also in the right markets at the right time, noting the accelerating shift to using digital technology in the medical and self-care solutions space. More than fast-changing, the pace of digital adoption is actually in hypergrowth, with everything from Telemedicine to routine appointments being made and paid for through digital means. And while a massive market today, it’s only getting more significant. For CLTS, that growth provides an operating vision. For investors, it helps to model for more appropriate valuations, and in CLTS’s case, the bulls may be controlling the reigns.
A Win-Win Proposition
Likely, that win-win proposition is inspiring investors to buy into the CLTS story. They probably expect that through its Internet information technology and extensive data resources for accurate analysis, its VivaHealth platform can generate significant revenues. And by integrating life service resources such as physiotherapists, foot bathers, manicurists, beauticians, barbers, and medical professionals in the service areas, they may be right. CLTS thinks so. And by offering a one-stop shop for nearly all self-care, CLTS is also right to be optimistic.
Remember, being different is good. The VivaHealth platform specifically focuses on the vertical fields of skincare and foot bathing, beauty and makeup, manicure and haircut, and traditional Chinese massage for Asian communities. The platform also connects to providers offering foot bathing, a popular homeopathic used for relaxing feet and the foot nerves, improving blood flow, alleviating pain, releasing toxins, replenishing overall energy, and improving mood.
Remember, the Asian community isn’t immune to chronic pain, either. But they are more open to medicine-free alternatives and cures like those noted to treat nerve pain throughout their bodies. Treating feet is a predominant avenue to seek and get relief.
Massage Industry Growth Is Accelerating
But that’s been no secret. The Massage Services industry is expected to experience significant growth as the therapeutic benefits of industry services continue to be extolled. In addition, the industry’s mounting relationship with the healthcare sector is anticipated to provide growing sources of revenue for industry operators. CLTS included.
Remember, while doctors can meet with patients, it’s up to the patient to make conscious efforts to maintain self-care. And that’s where the VivaHealth platform has its chance to shine by making it easier for elderly Asians to engage in their self-care activities through an online ordering and offline service designed as a matching trading platform.
In best comparison, it’s like Uber ($UBER) is to transportation. But in this case, VivaHealth is targeted to provide lifestyle services that also target multi-billion dollar revenue-generating market opportunities. More excellent, they could potentially own the markets they serve.
Early Opportunity To Seize Potentially Massive Growth
Thus, targeting and penetrating specific market demographic opportunities could bode well for CLTS, noting that a first-to-market presence usually has long-term rewards. Moreover, with CLTS expecting VivaHealth USA to launch into major markets by the end of the year, they could earn the lion’s share of business from serving hundreds of cities and towns and millions of users and families.
Indeed, that’s the plan. And in the process, shareholder value can be built by CLTS leveraging the expertise and team experience in creating similar systems to VivaHealth USA. The expected result should have Earth Life Sciences delivering a platform utilizing AI (Artificial Intelligence) integrations and customization and implementation of advanced innovative software to facilitate the delivery of on-site Life Style Services to families across the United States.
Thus, for those liking to invest in innovative companies targeting vast market opportunities, CLTS may be a company to consider. Considering that at current prices, investors get a ground floor investment opportunity into a company embarking on a new and exciting segment of Personal Care, it may also be timely.
Disclaimers: Hawk Point Media, LLC. (HPM, LLC.) is responsible for the production and distribution of this content. HPM, LLC. is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by HPM, LLC. is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall HPM, LLC. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by HPM, LLC., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. HPM, LLC. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, HPM, LLC., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. HPM, LLC has not been compensated to produce and syndicate content for the company featured. As part of all content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.